Cargando…

The Effects of the Recombinant CCR5 T4 Lysozyme Fusion Protein on HIV-1 Infection

BACKGROUND: Insertion of T4 lysozyme (T4L) into the GPCR successfully enhanced GPCR protein stability and solubilization. However, the biological functions of the recombinant GPCR protein have not been analyzed. METHODS: We engineered the CCR5-T4L mutant and expressed and purified the soluble recomb...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jin, Qingwen, Chen, Hong, Wang, Xingxia, Zhao, Liandong, Xu, Qingchen, Wang, Huijuan, Li, Guanyu, Yang, Xiaofan, Ma, Hongming, Wu, Haoquan, Ji, Xiaohui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496087/ https://www.ncbi.nlm.nih.gov/pubmed/26154172 http://dx.doi.org/10.1371/journal.pone.0131894

Ejemplares similares

Recombinant expression of hen egg white lysozyme with the assistance of xylanase fusion partner in Pichia pastoris
por: Cui, Lin, et al.
Publicado: (2022)

Enhanced Expression and Functional Characterization of the Recombinant Putative Lysozyme-PMAP36 Fusion Protein
por: Rao, Zhili, et al.
Publicado: (2019)

The role of the N-terminal segment of CCR5 in HIV-1 Env-mediated membrane fusion and the mechanism of virus adaptation to CCR5 lacking this segment
por: Melikyan, Gregory B, et al.
Publicado: (2007)

Recombinant soluble CCR5 AND CXCR4 chemokine receptors as anti-HIV drug targets
por: Kurbatska, Victoria, et al.
Publicado: (2010)

Constitutively Active CCR5 Chemokine Receptors Differ in Mediating HIV Envelope-dependent Fusion
por: de Voux, Alex, et al.
Publicado: (2013)

Endocytosis and Recycling of the HIV Coreceptor Ccr5
por: Signoret, Nathalie, et al.
Publicado: (2000)

CCR5 Inhibitors and HIV-1 Infection
por: Latinovic, Olga S., et al.
Publicado: (2019)

The G41D mutation in the superoxide dismutase 1 gene is associated with slow motor neuron progression and mild cognitive impairment in a Chinese family with amyotrophic lateral sclerosis
por: Niu, Qi, et al.
Publicado: (2016)

Expression of Recombinant Human Lysozyme in Egg Whites of Transgenic Hens
por: Cao, Dainan, et al.
Publicado: (2015)

CCR5AS lncRNA variation differentially regulates CCR5, influencing HIV disease outcome
por: Kulkarni, Smita, et al.
Publicado: (2019)

Designing Ago2-specific siRNA/shRNA to Avoid Competition with Endogenous miRNAs
por: Ma, Hongming, et al.
Publicado: (2014)

Recombinant fusion protein by lysozyme and antibacterial peptide enhances ischemic wound healing via angiogenesis and reduction of inflammation in diabetic db/db mice
por: Li, Wei, et al.
Publicado: (2021)

The HIV co-receptor CCR5 regulates osteoclast function
por: Lee, Ji-Won, et al.
Publicado: (2017)

Beyond HIV infection: Neglected and varied impacts of CCR5 and CCR5Δ32 on viral diseases
por: Ellwanger, Joel Henrique, et al.
Publicado: (2020)

Characterization of Bioactive Recombinant Human Lysozyme Expressed in Milk of Cloned Transgenic Cattle
por: Yang, Bin, et al.
Publicado: (2011)

Purification and Characterization of Recombinant Human Lysozyme from Eggs of Transgenic Chickens
por: Wu, Hanyu, et al.
Publicado: (2015)

Clinical use of CCR5 inhibitors in HIV and beyond
por: Gilliam, Bruce L, et al.
Publicado: (2011)

The role of CCR5 in HIV-associated neurocognitive disorders
por: Riviere-Cazaux, Cecile, et al.
Publicado: (2022)

Lysozyme Inhibitors as Tools for Lysozyme Profiling: Identification and Antibacterial Function of Lysozymes in the Hemolymph of the Blue Mussel
por: Vanderkelen, Lise, et al.
Publicado: (2023)

Two HIV-1 Variants Resistant to Small Molecule CCR5 Inhibitors Differ in How They Use CCR5 for Entry
por: Berro, Reem, et al.
Publicado: (2009)

Analysis of Two Lysozyme Genes and Antimicrobial Functions of Their Recombinant Proteins in Asian Seabass
por: Fu, Gui Hong, et al.
Publicado: (2013)

A novel DYNC1H1 mutation causing spinal muscular atrophy with lower extremity predominance
por: Niu, Qi, et al.
Publicado: (2015)

Development of a CCR5-tropic HIV-1 fusion inhibition assay amenable to high-throughput screening for topical microbicides
por: Beer, B, et al.
Publicado: (2006)

CCR5 Haplotypes and Mother-to-Child HIV Transmission in Malawi
por: Pedersen, Bonnie R., et al.
Publicado: (2007)

Natural anti-CCR5 antibodies in HIV-infection and -exposure
por: Lopalco, Lucia
Publicado: (2011)

CCR5 inhibitors: Emerging promising HIV therapeutic strategy
por: Rao, Padmasri Kutikuppala Surya
Publicado: (2009)

Accelerated Immunodeficiency by Anti-CCR5 Treatment in HIV Infection
por: Weinberger, Ariel D., et al.
Publicado: (2009)

CCR5 as a Natural and Modulated Target for Inhibition of HIV
por: Burke, Bryan P., et al.
Publicado: (2013)

CCR5 and HIV Infection, a View from Brussels
por: Parmentier, Marc
Publicado: (2015)

Targeting CCR5 trafficking to inhibit HIV-1 infection
por: Boncompain, Gaelle, et al.
Publicado: (2019)

Reduced CCR5 expression among Uganda HIV controllers
por: Nyiro, Brian, et al.
Publicado: (2023)

People with HIV have higher percentages of circulating CCR5+ CD8+ T cells and lower percentages of CCR5+ regulatory T cells
por: van Eekeren, Louise E., et al.
Publicado: (2022)

A sliding-bulge structure at the Dicer processing site of pre-miRNAs regulates alternative Dicer processing to generate 5′-isomiRs
por: Ma, Hongming, et al.
Publicado: (2016)

Association of chemokine receptor gene (CCR2-CCR5) haplotypes with acquisition and control of HIV-1 infection in Zambians
por: Malhotra, Rakhi, et al.
Publicado: (2011)

Estimating the Threshold Surface Density of Gp120-CCR5 Complexes Necessary for HIV-1 Envelope-Mediated Cell-Cell Fusion
por: Mulampaka, Shiva Naresh, et al.
Publicado: (2011)

Production of Transgenic-Cloned Pigs Expressing Large Quantities of Recombinant Human Lysozyme in Milk
por: Lu, Dan, et al.
Publicado: (2015)

Lysozyme Aptamer-Functionalized Magnetic Nanoparticles for the Purification of Lysozyme from Chicken Egg White
por: Luo, Ruiping, et al.
Publicado: (2019)

Blockade of chemokine-induced signalling inhibits CCR5-dependent HIV infection in vitro without blocking gp120/CCR5 interaction
por: Grainger, David J, et al.
Publicado: (2005)

CCR5 promoter activity correlates with HIV disease progression by regulating CCR5 cell surface expression and CD4 T cell apoptosis
por: Joshi, Anjali, et al.
Publicado: (2017)

The Geographic Spread of the CCR5 Δ32 HIV-Resistance Allele
por: Novembre, John, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_c4ak0c1cte4rt25dgr4apc4nu8